Company Filing History:
Years Active: 2019
Title: Mary Louise Garcia: Innovator in Lateral Flow Immunoassay Technology
Introduction
Mary Louise Garcia is a prominent inventor based in Fitzroy North, Australia. She has made significant contributions to the field of immunoassay technology, particularly through her innovative work on synthetic thread-based systems. Her dedication to advancing medical diagnostics has led to the development of a unique patent that enhances the detection of analytes in biological samples.
Latest Patents
Mary Louise Garcia holds a patent for a synthetic thread-based lateral flow immunoassay. This invention relates to systems, devices, and methods designed for detecting analytes in biological samples. The patent outlines a lateral flow immunofluorescent assay device that includes synthetic polymer threads, which facilitate the movement of fluid samples through various zones for effective detection. The device features a sample loading zone, a detection zone with an immobilized capture reagent, and an intermediate zone containing a fluorescent detection reagent. This innovative approach allows for the formation of fluorescently labeled analytes, enhancing the accuracy and efficiency of diagnostic testing.
Career Highlights
Mary Louise Garcia is associated with Lumos Diagnostics IP Pty Ltd, where she continues to develop and refine her groundbreaking technologies. Her work has positioned her as a key figure in the field of medical diagnostics, contributing to advancements that have the potential to improve patient outcomes.
Collaborations
Mary Louise collaborates with notable colleagues, including William Samuel Hunter and Sacha Marie Dopheide. These partnerships foster an environment of innovation and creativity, driving forward the development of new diagnostic solutions.
Conclusion
Mary Louise Garcia's contributions to the field of lateral flow immunoassay technology exemplify her commitment to innovation in medical diagnostics. Her patent for synthetic thread-based systems represents a significant advancement in the detection of biological analytes. Through her work at Lumos Diagnostics IP Pty Ltd and her collaborations with esteemed colleagues, she continues to make a lasting impact in the field.